A Better Way To Play The Earnings Game?
Given the ability of earnings reports to catapult stock prices higher in a short period of time, the authors of today’s article state “It’s no… Read More »A Better Way To Play The Earnings Game?
Investing and Market Analysis
Remdesivir’s COVID-19 Success Could Create A Big “Piggyback” Opportunity For This Under-The-Radar Biotech
There is currently only one drug that has demonstrated the potential to be a safe and effective treatment for COVID-19 in clinical trials: Gilead Sciences’… Read More »Remdesivir’s COVID-19 Success Could Create A Big “Piggyback” Opportunity For This Under-The-Radar Biotech
Following The Insiders Towards Returns
Restrictions put in place to help reduce the spread of COVID-19 are beginning to be eased in the U.S. and many other countries. At the… Read More »Following The Insiders Towards Returns
The Right Stocks Right Now: 3 Penny Stocks With “Strong Buy” Ratings And “Massive Upside Potential”
“We’re not in a true bull market – not by a long shot – but the recent bear has pushed prices down and the current… Read More »The Right Stocks Right Now: 3 Penny Stocks With “Strong Buy” Ratings And “Massive Upside Potential”
The Upsides Of Low-Priced Stocks – And 2 Top Biotech Stocks Under $10
When it comes to low-priced (under-$10) stocks, the author of today’s article acknowledges that “These types of equities…tend to be exceptionally risky and highly volatile… Read More »The Upsides Of Low-Priced Stocks – And 2 Top Biotech Stocks Under $10
The Bears vs. The Bulls On “The Hottest Battleground Stock In Cancer Treatment”
It’s “arguably the most intense battleground stock the biotech oncology sector has ever witnessed,” declares the author of today’s article in regards to the stock… Read More »The Bears vs. The Bulls On “The Hottest Battleground Stock In Cancer Treatment”
2 “Compelling” Biotech Stocks That Just Won The Ultimate Prize (FDA Approval)
FDA approval is the ultimate prize in the biotech industry – and one of the few major catalysts for biotech stocks. As a result, having… Read More »2 “Compelling” Biotech Stocks That Just Won The Ultimate Prize (FDA Approval)
3 Biotech/Pharma Stocks With Potential Clinical Trial Catalysts This Quarter
“In light of the ongoing COVID-19 pandemic, a number of pharma companies have postponed new study starts and have paused enrollment/screening in their clinical trials.… Read More »3 Biotech/Pharma Stocks With Potential Clinical Trial Catalysts This Quarter
3 Underappreciated Cannabis Stocks With High Upside Potential
How are marijuana stocks performing in the current environment? Today’s article notes that, “Despite solid indications that cannabis operations are one of the few sectors… Read More »3 Underappreciated Cannabis Stocks With High Upside Potential
Large- And Small-Cap Biotech Picks For Aggressive Growth Accounts
While the five biotech stocks highlighted in today’s article are a mix of large-cap leaders in the space and small-cap companies with massive upside potential,… Read More »Large- And Small-Cap Biotech Picks For Aggressive Growth Accounts